[1]
Fatima Qurratulain, Shahid Khan, Abdullah Khan, Mujahid Iqbal, Masood Ahmed, Irum Malik, “Changes in Cardiovascular Risk-Factor Profiles among Patients with Type 2 Diabetes Mellitus Receiving Dapagliflozin and Valsartan: A Prospective Observational Cohort Study”, Pakistan Journal of Medical & Health Sciences, vol. 17, no. 12, p. 950, Dec. 2023.